Press Releases About Continuing Research into New Drug Therapies for PNH

Posted on November 9, 2016

Achillion slumps 33% on potential safety issue with PNH candidate ACH-4471 Read Here

Interim analysis of post-marketing surveillance of eculizumab for paroxysmal nocturnal hemoglobinuria in Japan Read Here

Akari Therapeutics to Present Abstract on Potential Once Weekly PAS-Coversin at the 58th Annual Meeting of the American Society of Hematology Read Here

Researchers to Present New Phase 1/2 Data on ALXN1210 in Patients with PNH at ASH 2016 Annual Meeting Read Here

Coversin: A Novel Complement Inhibitor for Inflammatory and Autoimmune Disease Read Here